DNA and RNA Banking Services Market Industry Report 2034: Size, Share, Trends and Opportunities

Bio-banking services are identified as one of the key areas in accelerating drug discovery to develop new therapeutic approaches, particularly in oncology indications.

Know more about this report: Download Sample Report

Such a multi-disciplinary approach is applied for therapy monitoring, disease prediction, preventive measures, drug discovery, and optimization. As a result, the market for DNA & RNA banking services is expected witness significant market growth over the forecast period.

Hence, the rise in cancer cases worldwide is anticipated to drive the DNA & RNA banking services industry growth. Cancer is the second largest death cause in the U.S. alone, after heart diseases. As per the estimates of the American Cancer Society, there are more than 1.8 million new cases of cancer, by 2020, in the U.S. alone. It is being estimated that around 606,520 people in the U.S., die after contracting cancer. High cancer prevalence, resulted in demand for cancer research, which further propels DNA & RNA banking services demand.

Know more about this report: Download Sample Report

DNA & RNA Banking Services Market Report Scope

The market is primarily segmented on the basis of service, specimen, application, end-use, and geographic region.

Source: Polaris Market Research Analysis

Know more about this report: Download Sample Report

Insight by Service

The storage device segment of DNA & RNA banking services market accounted for the largest revenue share, in 2020. This is high market share is attributed to the availability of high-quality biospecimens for research purposes. Reliable long-term stabilization and storage solutions are critical to the development of biobanks. Biological samples need to be stored in temperature-controlled storage facilities of up to -496oCelsius.

The easy availability of these systems, such as compound and arktic systems manufactured by SPT Labtech, could be easily configured to have -80oCelsius of temperature. The platforms are well suited for 2D barcoded tubes to fulfill storage volumes from micro-liters to 1.2 mL. Hence, the presence of ambient storage facilities positively impacts the market segment’s demand.

The quality control market segment is expected to witness the highest growth rate over the study period. The presence of several guidelines to improve the quality of specimens. Bio-specimen Reporting for Improved Study Quality strengthens the publication related to the bio-specimen research. France on the other hand has already introduced specific region-specific guidelines to regulate DNA & RNA banking services.

Insight by Specimen

In 2020, the blood market segment of DNA & RNA banking services market held the largest share. It is the most used sample type by clinicians for routine lab tests. It is the most common non-invasive biomarker specimen type for cancer studies. Moreover, blood sample collection time does not interfere with the count of DNA and RNA.

Blood collection is one type of certified primary skill for front-line medical workers. It requires special collection tubes and venipuncture. Additional specimen collection to store them in biobanks does not burden the patient, which complicates blood collection. Moreover, serum and plasma are mostly preferred over cell-free DNA, protein, or hormone for sample collection.

The buccal swaps market segment is projected to witness a lucrative growth rate over the study period. The collection of buccal swabs samples is one of the fastest methods, which does not require any medically trained professional. Mostly, hair samples are used in forensic studies. Moreover, the rise in COVID cases has increased exponentially, owing to the increase in market demand for swabbing testing.

Insight by End Use

In 2020, the academic market segment held the largest revenue share. A huge pool of researchers in research institutions involved in any kind of research is largely responsible for such growth. A paradigm shift towards biomarker therapy, personalized medicine, and tailored therapies offered by biomarkers also attributed to the growth of the segment and market for DNA & RNA banking services.

Academic institutions are involved to understand differences between several treatment types and their response type. Colorado Center for Personalized Medicine (CCPM) is one such type of institute which is involved in personalized medicine. This biobank collects and stores different biological samples.

Hospitals market segments of DNA & RNA banking services industry are projected to witness a lucrative growth rate over the assessment period. This is primarily due to strong relations and collaborations with associations, for instance, more than 80,000 have already consented to transfer rights of their biological sample to Partners Biobank to the Spaulding Rehabilitation Hospital, Massachusetts General Hospital, and McLean Hospital.

Geographic Overview

In 2020, the North America market for DNA & RNA banking services accounted for over 30% of the global market. This high share is attributed to the presence of a wide network of biobanks and the efforts taken by them in the country. The Canadian Tumor Repository Network is a non-profit bio-bank network financed by the Government of Canada. It collects and stores blood, tissue, and saliva samples of cancer patients for further research purposes.

The U.S. government also supports a comprehensive network of biobanks in the country. The Cooperative Human Tissue Network is one such organization that is supported and funded by the National Cancer Institute. It usually provides blood and tissue microarrays for existing specimens from cancer patients for varied research themes.

Asia Pacific market for DNA & RNA banking services is projected to witness the highest growth rate over the study period. Demand in the region is primarily due to awareness among stakeholders about the concept of bio-banking through conferences and industry consortiums. For instance, in September 2020, Japan hosted the International Conference on Advanced Bio-banking and Biotechnology to spread awareness in Asian countries.

List Of Key Companies

• EasyDNA
• 23andMe, Inc.
• GoodCell
• ProteoGenex
• LGC Biosearch Technologies
• DNA Genotek Inc.
• US Biolab Corporation, Inc.
• Thermo Fisher Scientific, Inc.
• deCODE genetics
• Infinity Biologix
• Brooks Life Sciences
• PreventionGenetics

Recent Industry Developments

In July 2026, 300K Solutions announced the initiation of a technical validation study with the International Agency for Research on Cancer, a specialized agency of the World Health Organization. The aim of the study is to compare the quality and functionality of DNA samples stored at room temperature with that of samples stored under the traditional −80°C conditions. The project aims to assess alternative methods of storing genomic samples and their potential future use in long-term biobanking. (Source: 300K Solutions)

In April 2026, Integrated Gulf Biosystems announced the availability of Azenta Life Sciences’ integrated automated storage and advanced cryogenic solutions in India. The expanded offering supports biological sample intake, automated storage and retrieval, cryogenic preservation and scalable biobanking workflows. Azenta’s broader sample-management service portfolio includes the storage of biological materials including DNA and RNA. This development will improve access to biobanking infrastructure for Indian research labs and life science organizations, ensuring more reliable handling and long-term preservation of valuable research specimens.(Source: Integrated Gulf Ecosystem)

Virchow Medical and PreciseMDX announced a strategic partnership in December 2025 to develop a digital platform for the Virchow Vault liquid companion specimen biobank. The proposed platform will allow clinicians to request genomic testing from biological specimens already collected and stored within the repository. The partnership will enhance access to stored samples for oncology testing and targeted therapy research by linking biobanked specimens with digital laboratory ordering workflows. (Source: PreciseMDX)